(+)-schisandrin B multiple interactions ISO RGD:2292706 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADH5 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine decreases expression ISO RGD:1615209 6480464 1, 2-Dimethylhydrazine results in decreased expression of ADH5 mRNA CTD PMID:22206623 12-hydroxylauric acid affects binding EXP 6480464 12-hydroxydodecanoic acid binds to ADH5 protein CTD PMID:12196016 , PMID:12604204 12-hydroxylauric acid increases oxidation EXP 6480464 ADH5 protein results in increased oxidation of 12-hydroxydodecanoic acid CTD PMID:19428350 17alpha-ethynylestradiol increases expression ISO RGD:1615209 6480464 Ethinyl Estradiol results in increased expression of ADH5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1615209 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADH5 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1615209 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADH5 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2292706 6480464 Tetrachlorodibenzodioxin results in increased expression of ADH5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1615209 6480464 Tetrachlorodibenzodioxin affects the expression of ADH5 mRNA CTD PMID:21570461 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of ADH5 protein CTD PMID:31675489 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1615209 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of ADH5 mRNA CTD PMID:18648102 8'-apo-beta,psi-caroten-8'-al increases expression EXP 6480464 apocarotenal results in increased expression of ADH5 mRNA CTD PMID:17034753 8-hydroxyoctanoic acid increases oxidation EXP 6480464 ADH5 protein results in increased oxidation of 8-hydroxyoctanoic acid CTD PMID:19428350 acetamide decreases expression ISO RGD:2292706 6480464 acetamide results in decreased expression of ADH5 mRNA CTD PMID:31881176 alcohol decreases expression EXP 6480464 Alcohols results in decreased expression of ADH5 protein CTD PMID:24300283 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of ADH5 mRNA CTD PMID:23724009 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of ADH5 mRNA CTD PMID:33167477 antirheumatic drug increases expression EXP 6480464 Antirheumatic Agents results in increased expression of ADH5 mRNA CTD PMID:24449571 aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of ADH5 protein CTD PMID:33212167 arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ADH5 protein] CTD PMID:26598702 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of ADH5 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ADH5 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO RGD:1615209 6480464 Benzo(a)pyrene results in increased expression of ADH5 mRNA CTD PMID:22228805 beta-carotene increases expression EXP 6480464 beta Carotene results in increased expression of ADH5 mRNA CTD PMID:17034753 bifenthrin increases expression ISO RGD:1615209 6480464 bifenthrin results in increased expression of ADH5 mRNA CTD PMID:26071804 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ADH5 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:2292706 6480464 bisphenol A results in decreased expression of ADH5 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A increases methylation ISO RGD:2292706 6480464 bisphenol A results in increased methylation of ADH5 gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:2292706 6480464 bisphenol A results in increased expression of ADH5 mRNA CTD PMID:25181051 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of ADH5 mRNA CTD PMID:23369406 choline multiple interactions ISO RGD:1615209 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ADH5 gene CTD PMID:20938992 cimetidine multiple interactions EXP 6480464 Cimetidine inhibits the reaction [ADH5 protein results in increased oxidation of S-hydroxymethylglutathione] CTD PMID:23220590 clofibrate decreases expression ISO RGD:1615209 6480464 Clofibrate results in decreased expression of ADH5 mRNA CTD PMID:17585979 clozapine multiple interactions EXP 6480464 [Cuprizone co-treated with Clozapine] results in increased expression of ADH5 protein CTD PMID:34122009 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of ADH5 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:1615209 6480464 Asbestos, Crocidolite results in decreased expression of ADH5 mRNA CTD PMID:29279043 Cuprizon multiple interactions EXP 6480464 [Cuprizone co-treated with Clozapine] results in increased expression of ADH5 protein CTD PMID:34122009 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of ADH5 mRNA CTD PMID:25562108 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of ADH5 protein CTD PMID:31675489 decanoic acid multiple interactions EXP 6480464 decanoic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione] CTD PMID:19428350 dextran sulfate multiple interactions ISO RGD:1615209 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADH5 mRNA CTD PMID:29950665 diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ADH5 protein] CTD PMID:26598702 dibutyl phthalate decreases expression ISO RGD:1615209 6480464 Dibutyl Phthalate results in decreased expression of ADH5 mRNA CTD PMID:17361019 , PMID:21266533 dicrotophos decreases expression EXP 6480464 dicrotophos results in decreased expression of ADH5 mRNA CTD PMID:28302478 dodecanedioic acid multiple interactions EXP 6480464 dodecanedioic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione] CTD PMID:19428350 dodecanoic acid multiple interactions EXP 6480464 lauric acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione] CTD PMID:19428350 ethanol multiple interactions ISO RGD:1615209 6480464 [Zinc co-treated with Ethanol] results in increased expression of ADH5 mRNA CTD PMID:19637192 ethanol multiple interactions EXP 6480464 S-Nitrosoglutathione promotes the reaction [ADH5 protein results in increased oxidation of Ethanol] CTD PMID:19038239 ethanol increases oxidation EXP 6480464 ADH5 protein results in increased oxidation of Ethanol CTD PMID:19038239 fenthion increases expression ISO RGD:1615209 6480464 Fenthion results in increased expression of ADH5 mRNA CTD PMID:34813904 folic acid multiple interactions ISO RGD:1615209 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ADH5 gene CTD PMID:20938992 folic acid decreases expression ISO RGD:1615209 6480464 Folic Acid results in decreased expression of ADH5 mRNA CTD PMID:25629700 folpet increases expression ISO RGD:1615209 6480464 folpet results in increased expression of ADH5 mRNA CTD PMID:31558096 formaldehyde increases metabolic processing EXP 6480464 ADH5 protein results in increased metabolism of Formaldehyde CTD PMID:12604204 formaldehyde multiple interactions EXP 6480464 S-Nitrosoglutathione promotes the reaction [ADH5 protein results in increased oxidation of Formaldehyde] CTD PMID:19038239 formaldehyde increases oxidation EXP 6480464 ADH5 protein results in increased oxidation of Formaldehyde CTD PMID:19038239 glutathione multiple interactions EXP 6480464 Glutathione inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione] CTD PMID:19428350 gold atom decreases expression EXP 6480464 Gold results in decreased expression of ADH5 mRNA CTD PMID:25523186 gold(0) decreases expression EXP 6480464 Gold results in decreased expression of ADH5 mRNA CTD PMID:25523186 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of ADH5 mRNA CTD PMID:20044591 ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of ADH5 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1615209 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ADH5 gene CTD PMID:20938992 methidathion increases expression ISO RGD:1615209 6480464 methidathion results in increased expression of ADH5 mRNA CTD PMID:34813904 methylparaben decreases expression EXP 6480464 methylparaben results in decreased expression of ADH5 mRNA CTD PMID:31745603 nonanoic acid multiple interactions EXP 6480464 pelargonic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione] CTD PMID:19428350 octan-1-ol increases metabolic processing EXP 6480464 ADH5 protein results in increased metabolism of 1-Octanol CTD PMID:19822198 octan-1-ol multiple interactions EXP 6480464 Pentachlorophenol inhibits the reaction [ADH5 protein results in increased metabolism of 1-Octanol] CTD PMID:19822198 octanoic acid multiple interactions EXP 6480464 octanoic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione] CTD PMID:19428350 p-toluidine increases expression ISO RGD:2292706 6480464 4-toluidine results in increased expression of ADH5 mRNA CTD PMID:27638505 paracetamol affects expression ISO RGD:1615209 6480464 Acetaminophen affects the expression of ADH5 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ADH5 mRNA CTD PMID:21420995 more ... pentachlorophenol multiple interactions EXP 6480464 Pentachlorophenol inhibits the reaction [ADH5 protein results in increased metabolism of 1-Octanol] CTD PMID:19822198 phlorizin decreases expression ISO RGD:1615209 6480464 Phlorhizin results in decreased expression of ADH5 mRNA CTD PMID:22538082 picoxystrobin increases expression EXP 6480464 picoxystrobin results in increased expression of ADH5 mRNA CTD PMID:33512557 potassium chromate decreases expression EXP 6480464 potassium chromate(VI) results in decreased expression of ADH5 mRNA CTD PMID:22714537 progesterone multiple interactions ISO RGD:1615209 6480464 [Progesterone results in increased activity of PGR protein] which results in increased expression of ADH5 mRNA CTD PMID:15845616 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of ADH5 mRNA CTD PMID:21632981 rotenone increases expression EXP 6480464 Rotenone results in increased expression of ADH5 mRNA CTD PMID:33512557 S-(hydroxymethyl)glutathione multiple interactions EXP 6480464 Cimetidine inhibits the reaction [ADH5 protein results in increased oxidation of S-hydroxymethylglutathione] CTD PMID:23220590 S-(hydroxymethyl)glutathione increases oxidation EXP 6480464 ADH5 protein results in increased oxidation of S-hydroxymethylglutathione CTD PMID:23220590 S-methylglutathione multiple interactions EXP 6480464 S-methyl glutathione inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione] CTD PMID:19428350 S-nitrosoglutathione multiple interactions EXP 6480464 decanoic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione] more ... CTD PMID:19038239 , PMID:19428350 S-nitrosoglutathione multiple interactions ISO RGD:1615209 6480464 [SPL-334 results in decreased activity of ADH5 protein] which results in decreased metabolism of S-Nitrosoglutathione CTD PMID:26209236 S-nitrosoglutathione increases reduction EXP 6480464 ADH5 protein results in increased reduction of S-Nitrosoglutathione CTD PMID:19038239 , PMID:19428350 sebacic acid multiple interactions EXP 6480464 sebacic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione] CTD PMID:19428350 sodium fluoride increases expression ISO RGD:1615209 6480464 Sodium Fluoride results in increased expression of ADH5 protein CTD PMID:28918527 tetrachloromethane decreases expression ISO RGD:1615209 6480464 Carbon Tetrachloride results in decreased expression of ADH5 mRNA CTD PMID:31919559 tetrachloromethane decreases expression ISO RGD:2292706 6480464 Carbon Tetrachloride results in decreased expression of ADH5 mRNA CTD PMID:30723492 , PMID:31150632 tetrachloromethane multiple interactions ISO RGD:2292706 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADH5 mRNA] CTD PMID:31150632 thioacetamide decreases expression ISO RGD:2292706 6480464 Thioacetamide results in decreased expression of ADH5 mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO RGD:1615209 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADH5 mRNA CTD PMID:29950665 undecanoic acid multiple interactions EXP 6480464 undecanoic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione] CTD PMID:19428350 urethane decreases expression EXP 6480464 Urethane results in decreased expression of ADH5 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1615209 6480464 Valproic Acid affects the expression of ADH5 mRNA CTD PMID:17292431 zinc atom multiple interactions ISO RGD:1615209 6480464 [Zinc co-treated with Ethanol] results in increased expression of ADH5 mRNA CTD PMID:19637192 zinc(0) multiple interactions ISO RGD:1615209 6480464 [Zinc co-treated with Ethanol] results in increased expression of ADH5 mRNA CTD PMID:19637192